1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market – By Technology

1.3.2        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market – By Application

1.3.3        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market – By End-User

1.3.4        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market – By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Circulating Tumor Cell (CTC) Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific PEST Analysis

4.3         Experts Opinion

5.           Circulating Tumor Cell (CTC) Diagnostics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Rising Demand for Minimally Invasive Diagnostic Procedures

5.2         Market Restraints

5.2.1        Dearth of Skilled Professionals Performing Diagnostic Procedures

5.3         Market Opportunities

5.3.1        Untapped Potential of Emerging Economies

5.4         Future Trends

5.4.1        Technological Advancements in Isolation of Circulating Tumor Cell

5.5         Impact Analysis

6.           Circulating Tumor Cell (CTC) Diagnostics Market– Asia Pacific Analysis

6.1         Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis

7.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Technology

7.1         Overview

7.2         Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2020 & 2028 (%)

7.3         CTC detection and Enrichment Method

7.3.1        Overview

7.3.2        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.4         CTC Direct Detection Method

7.4.1        Overview

7.4.2        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.5         CTC Analysis

7.5.1        Overview

7.5.2        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Application

8.1         Overview

8.2         Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share, By Application - 2020 & 2028 (%)

8.3         Clinical/Liquid Biopsy

8.3.1        Overview

8.3.2        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        Risk Assessment

8.3.3.1          Overview

8.3.3.2          Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Screening and Monitoring

8.3.4.1          Overview

8.3.4.2          Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Research

8.4.1        Overview

8.4.2        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.1          Cancer Stem Cell & Tumorigenesis Research

8.4.2.1.1          Overview

8.4.2.1.2          Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.2          Drug/Therapy Development

8.4.2.2.1          Overview

8.4.2.2.2          Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – End user

9.1         Overview

9.2         Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Research and Academic Institutes

9.4.1        Overview

9.4.2        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Centers

9.5.1        Overview

9.5.2        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market – Geographic Analysis

10.1      Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market

10.1.1     Overview

10.1.2     Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

10.1.3     Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.4     Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.4.1       Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.4.2       Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.5     Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6     Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.6.1       China: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1       China: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.2       China: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.1.3       China: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.1.3.1     China: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.1.3.2     China: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.1.4       China: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6.2       Japan: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1       Japan: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.2       Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.2.3       Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.2.3.1     Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.2.3.2     Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.2.4       Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6.3       India: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1       India: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.2       India: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.3.3       India: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.3.3.1     India: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.3.3.2     India: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.3.4       India: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6.4       Australia: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.1       Australia: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.2       Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.4.3       Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.4.3.1     Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.4.3.2     Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.4.4       Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6.5       South Korea: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.1       South Korea: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.2       South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.5.3       South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.5.3.1     South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.5.3.2     South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.5.4       South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6.6       Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.1       Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.2       Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.6.3       Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.6.3.1     Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.6.3.2     Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.6.4       Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

11.        Impact of COVID-19 Pandemic on Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market

11.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      THERMO FISHER SCIENTIFIC INC.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      STEMCELL Technologies Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      QIAGEN

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      SCREENCELL

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      FLUXION BIOSCIENCES

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 6.             China: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 7.             China: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             China: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 9.             China: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 10.          China: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology– Revenue and Forecast to 2028 (US$ Million)

Table 12.          Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 16.          India: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology– Revenue and Forecast to 2028 (US$ Million)

Table 17.          India: Circulating Tumor Cell (CTC) Diagnostics Market, By Application– Revenue and Forecast to 2028 (US$ Million)

Table 18.          India: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/ Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 19.          India: Circulating Tumor Cell (CTC) Diagnostics Market, By Research– Revenue and Forecast to 2028 (US$ Million)

Table 20.          India: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User– Revenue and Forecast to 2028 (US$ Million)

Table 21.          Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 26.          South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 27.          South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 28.          South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 29.          South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 30.          South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 33.          Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 34.          Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 35.          Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 36.          Organic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 37.          Inorganic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 38.          Glossary of Terms, Circulating Tumor Cell (CTC) Diagnostics Market

LIST OF FIGURES

Figure 1.           Circulating Tumor Cell (CTC) Diagnostics Market Segmentation

Figure 2.           Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Overview

Figure 3.           CTC detection and Enrichment Method Held Largest Share of Technology Segment in Circulating Tumor Cell (CTC) Diagnostics Market

Figure 4.           China is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market, Industry Landscape

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2020 & 2028 (%)

Figure 10.        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 11.        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share, by Application - 2020 & 2028 (%)

Figure 14.        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

Figure 21.        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 25.        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 27.        China: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Japan: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        India: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Australia: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        South Korea: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 34.        Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)